Abstract:Introduction: Polygenic risk scores (PRSs) predict breast cancer (BC) risk and have shown utility for screening in European ancestry women (EUR). However, PRSs developed for non-European ancestry, particularly African American (AA) women, have limited predictive accuracy. Methods: We analyzed data from 17,454 BC cases and 19,093 controls in the African American Breast Cancer Genetics (AABCG) consortium, split into training (70%), tuning (10%), and testing (20%) sets. Genome-wide association analyses for overall BC, ER-positive BC, ER- negative BC and triple-negative BC (TNBC) were performed in the training dataset, controlling for age, genotyping platform, and the top 10 principal components. We built single-ancestry PRS models using forward stepwise selection (FSS), PRSice-2, PLINK C+T, Lassosum2, and LDpred2-auto. These were combined with published EUR 313-SNP models (330-SNP for TNBC) in the tuning set to obtain cross-ancestry models. Genome-wide cross-ancestry PRS methods, including CT-SLEB and PRScsx, were also used. We created an ensemble model by combining different PRS models across subtypes using ensemble-based approaches. All developed PRS models were then evaluated in the independent testing set. Additional validation was performed using the All of Us (AoU) study with 834 BC cases and 29,122 controls from the AA population. Results: The observed-scale SNP-based heritability was estimated at 0.29 (SE: 0.12) for overall BC risk, 0.43 (SE: 0.18) for ER-positive BC, 0.44 (SE: 0.24) for ER-negative BC, and 1.13 (SE: 0.40) for TNBC. The best models showed good discriminating capacity: ensemble-based models for overall (AUC=0.626) and ER-positive BC (AUC=0.626), and combined cross-subtype and cross-ancestry FSS models for ER-negative (AUC=0.647) and TNBC (AUC=0.654). The odds ratio per standard deviation was 1.63 (95% CI: 1.55, 1.71) for the ensemble-based PRS of overall BC risk, with an estimated life risk of 28% for the top 1%. The cross-ancestry model using CT-SLEB combined with the EUR 313-SNP model was validated (AUC=0.61) among AA women in the AoU study. Conclusion: We developed PRSs with improved discriminating ability for BC risk in women with African ancestry. Cross- ancestry and subtype learning enhanced model performance. These findings indicate common variation has a larger role in BC in AA women than previously reported, warranting further validation in external AA populations and clinical evaluation. Citation Format: James L. Li, Haoyu Zhang, Julian C McClellan, Guimin Gao, Kevin Wang, Julie R. Palmer, Olufunmilayo I. Olopade, Christopher A. Haiman, Dezheng Huo. Development of cross-ancestry polygenic risk. scores for breast cancer in women of African ancestry [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl) nr A021.

Polygenic prediction of major depressive disorder and related traits in African ancestries UK Biobank participants.

A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank

Polygenic Prediction of Type 2 Diabetes in Africa

Exome-wide screening identifies novel rare risk variants for major depression disorder

Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations

All of Us diversity and scale improve polygenic prediction contextually with greatest improvements for under-represented populations

Transferability of genetic risk scores in African populations

Differential Results of Polygenic Risk Scoring for Multiple Sclerosis in European and African American Populations

Polygenic prediction and GWAS of depression, PTSD, and suicidal ideation/self-harm in a Peruvian cohort

Analysis of genetic differences between psychiatric disorders: Exploring pathways and cell-types/tissues involved and ability to differentiate the disorders by polygenic scores

Genetic architecture and socio-environmental risk factors for major depressive disorder in Nepal

Analyses of biomarker traits in diverse UK biobank participants identify associations missed by European-centric analysis strategies

Abstract A021: Development of cross-ancestry polygenic risk. scores for breast cancer in women of African ancestry

Genetic Risk Scores for Cardiometabolic Traits in Sub-Saharan African Populations

Prevalence and correlates of common mental disorders among participants of the Uganda Genome Resource: Opportunities for psychiatric genetics research

Using phenotype risk scores to enhance gene discovery for generalized anxiety disorder and posttraumatic stress disorder

Association between polygenic risk scores combined with clinical characteristics and antidepressant efficacy

Risk Stratification for Bipolar Disorder Using Polygenic Risk Scores Among Young High-Risk Adults

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank

Distinguishing different psychiatric disorders using DDx-PRS

Mendelian Randomisation Study of Body Composition and Depression in People of East Asian Ancestry Highlights Potential Setting-Specific Causality